Mortality in nursing home residents stratified according to subtype of dementia : a longitudinal study over three years

Article

VOSSIUS, Corinna | BERGH, Sverre | SELBAEK, Geir | BENTH, Jurate Saltyte | MYHRE, Janne | AAKHUS, Eivind | LICHTWARCK, Bjørn

BACKGROUND: There are several subtypes of dementia caused by different pathophysiology and with different clinical characteristics. Irrespective subtype, the disease is progressive, eventually leading to the need for care and supervision on a 24/7 basis, often provided in nursing homes (NH). The progression rate and course of the disease might vary according to subtype. The aim of this study was to explore whether the mortality rate for NH residents varied according to the subtype of dementia. METHODS: NH residents were followed from admission to NH over a period of 36 months or until death with annual follow-up examinations. Demographic and clinical data were collected. The diagnosis of dementia and its subtype at baseline (BL) were set according to international accepted criteria. Kaplan-Meier analysis was performed to estimate median survival time. A Cox regression model was estimated to assess the impact of dementia diagnosis and demographic and clinical variables on mortality. RESULTS: A total of 1349 participants were included. When compared to persons with Alzheimer's disease (AD), persons with frontotemporal dementia (FTD) and dementia with Lewy bodies or Parkinson's disease dementia (DLB/PDD) were younger and had more neuropsychiatric symptoms. Median survival for the total sample was 2.3 years (95% confidence interval: 2.2-2.5). When compared to persons with AD, having no dementia or unspecified dementia was associated with higher mortality, while we found similar mortality in other subtypes of dementia. Higher age, male gender, poorer general health, higher dependency in activities of daily living, and more affective symptoms were associated with higher mortality. CONCLUSION: Mortality did not differ across the subtypes of dementia, except in persons with unspecified dementia or without dementia, where we found a higher mortality. With a median survival of 2.3 years, NH residents are in the last stage of their lives and care and medical follow-up should focus on a palliative approach. However, identifying the subtype of dementia might help carers to better understand and address neuropsychiatric symptoms and to customize medical treatment.

http://dx.doi.org/10.1186/s12877-022-02994-9

Voir la revue «BMC GERIATRICS, 22»

Autres numéros de la revue «BMC GERIATRICS»

Consulter en ligne

Suggestions

Du même auteur

Mortality in nursing home residents stratifie...

Article indépendant | VOSSIUS, Corinna | BMC GERIATRICS | n°1 | vol.22

BACKGROUND: There are several subtypes of dementia caused by different pathophysiology and with different clinical characteristics. Irrespective subtype, the disease is progressive, eventually leading to the need for care and supe...

Mortality in nursing home residents stratifie...

Article indépendant | VOSSIUS, Corinna | BMC GERIATRICS | n°1 | vol.22

BACKGROUND: There are several subtypes of dementia caused by different pathophysiology and with different clinical characteristics. Irrespective subtype, the disease is progressive, eventually leading to the need for care and supe...

Cause and place of death in Norwegian nursing...

Article | VOSSIUS, Corinna | Scandinavian journal of public health

Background: Nursing home (NH) residents are in their last phase of life, and two aims of the NH's medical care in Norway is to prevent unnecessary hospital admissions that would not benefit the resident and to facilitate a peacefu...

De la même série

Dying in residential care homes during the ea...

Article | PRESTON, Nancy | BMC GERIATRICS | n°1 | vol.25

BACKGROUND: Early in the COVID-19 pandemic, care homes (long-term care facilities) globally were severely impacted in many ways, including end-of-life care and death of residents. They experienced significantly elevated mortality ...

Palliative use of midazolam in acute geriatri...

Article | PROD'HOMME, Chloé | BMC GERIATRICS | n°1 | vol.25

INTRODUCTION: End-of-life management in acute geriatric units (AGUs) is frequent but complex. Midazolam is the drug of choice for the management of refractory symptoms (particularly in the context of sedation) at the end of life. ...

Implementing advance care planning in palliat...

Article | WILKIN, Katie | BMC GERIATRICS | n°1 | vol.24

BACKGROUND: Advance care planninganning (ACP) is a priority within palliative care service provision. Nurses working in the community occupy an opportune role to engage with families and patients in ACP. Carers and family members ...

Chinese older adults' prior-to-death disabili...

Article | CHEN, Chuqian | BMC GERIATRICS | n°1 | vol.24

BACKGROUND: Disability prior to death complicates end-of-life care. The present study aimed to explore the prior-to-death disability profiles of Chinese older adults, the profiles' links to end-of-life care arrangements and place ...

Evaluation of a knowledge-attitude-practice m...

Article | XIE, Xifeng | BMC GERIATRICS | n°1 | vol.24

Background: The global aging population presents challenges that are particularly acute in China. Older Chinese adults’ attitudes towards death significantly impact their quality of life. Death education is crucial for promo...

Chargement des enrichissements...